BioSmart Fact File 261.3 orbitbiotech orbitbiosmart Replacing insulin through stem cell-derived pancreatic cells under the skin Sanford-Burnham Medical Research Institute (Sanford-Burnham) and UC San Diego School of Medicine scientists have shown that by encapsulating immature pancreatic cells derived from human embryonic stem cells (hESC), and implanting them under the skin in animal models of diabetes, sufficient insulin is produced to maintain glucose levels without unwanted potential trade-offs of the technology. The research suggests that encapsulated hESC-derived insulin-producing cells hold great promise as an effective and safe cell-replacement therapy for insulin-dependent diabetes.
Posted on: Thu, 08 May 2014 13:20:56 +0000
Recently Viewed Topics
© 2015